Utrophin-A promoter (UTRN-A promoter)

The utrophin-A promoter is a critical regulatory region of the UTRN gene, which encodes utrophin, a large cytoskeletal protein and autosomal paralogue of dystrophin [1.1.4, 1.2.3]. In healthy adult muscle, utrophin expression is primarily restricted to the neuromuscular and myotendinous junctions, whereas dystrophin is distributed throughout the sarcolemma [1.2.4]. In patients with Duchenne Muscular Dystrophy (DMD), the absence of dystrophin leads to membrane instability and progressive muscle wasting [1.3.2]. The utrophin-A promoter and its associated transcription machinery, including factors like GABP and Sp1, serve as therapeutic targets because upregulating utrophin can functionally compensate for the lack of dystrophin, stabilizing the muscle fiber membrane [1.2.2, 1.5.2]. Pharmacological strategies, such as small molecule utrophin modulators like ezutromid and artificial zinc finger transcription factors (e.g., Jazz), aim to activate this promoter to achieve widespread sarcolemmal expression of utrophin [1.1.2, 1.5.4]. While early clinical trials with small molecules faced challenges regarding sustained efficacy, the target remains a high-priority area for mutation-agnostic DMD therapies [1.5.1, 1.5.3].

Other names

Utrophin promoterUTRN promoterUtrophin-A regulatory elementUtrophin gene transcription machineryUtrophin-A 5-prime-UTR

Transcriptional activation of the utrophin-A promoter to increase endogenous utrophin protein levels, which functionally compensates for the absence of dystrophin at the sarcolemma [1.1.2, 1.3.3].